Digital Health Deals Sparked in 2016

Virtually every aspect of the healthcare industry now relies on some form of technology or data to improve patient outcomes, reduce costs or readmissions, or to analyze masses of population health data in order to manage that population better. Even more pressing in 2017 is the need to secure all that data and technology. But […]

Q2:16 Results Defy Brexit and Other Uncertainties

You’ve seen the headlines: Global mergers and acquisitions slid in the first half of 2016, as did the combined value. The number of middle market deals completed in the second quarter fell to levels not seen since 2009. Buyers are walking away from targets that could be affected by sudden changes in tax regulations. It’s […]

Digital Health Deals Strike New Heights

The digital health sector is on fire in the first half of 2016. Through June 24 we’ve recorded 82 transactions with a business-to-business eHealth company as the target. Sixteen of those were announced in June alone. (We don’t cover consumer-facing health apps or social media platforms.) In the first half of 2015, just 60 deals […]

Quintiles/IMS Merger Keeps Lab Sector Humming

Laboratories are big business, and they’re trading for very strong multiples these days. This year in particular, we’ve seen a lot of global M&A action around contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs). The most recent announcement was the all-stock merger of equals between Quintiles (NYSE: Q) and IMS Health Holdings (NYSE: IMS). […]